Pharmacology
 |
|
21 january 2015 05:15:20 |
| Pegylated IFN-?-2a and ribavirin in the treatment of hepatitis C infection in children (Expert Opinion on Drug Safety) |
|
Tweet Expert Opinion on Drug Safety, Ahead of Print.
|
| 102 viewsCategory: Pharmacology |
 Targeting the 5?-AMP-activated protein kinase and related metabolic pathways for the treatment of prostate cancer (Expert Opinion on Therapeutic Targets)Nanocarrier-mediated drugs targeting cancer stem cells: an emerging delivery approach (Expert Opinion on Drug Delivery) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
